Billionaire hedge funder Jim Chanos is still short Valeant
Reuters
"I'm still short Valeant," Chanos said in an interview with CNBC at the Sohn Conference on Friday.
The pharmaceutical company is a former stock market darling that's been hit with SEC investigations, Senate investigations, and a precipitous decline in its stock price.
Chanos said that everybody is using metrics that are "just as bad as Valeant's accounting."
Hedge fund manager Bill Ackman, who is long Valeant, on Monday told CNBC he hopes to turn the company around.
Ackman joined Valeant's board in March as the company's CEO, Mike Pearson, announced his departure from the firm.
Valeant's stock has plunged about 86% in the past year and almost 70% since October.
More to come...
NOW WATCH: How ISIS makes over $1 billion a year
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- FSSAI in process of collecting pan-India samples of Nestle's Cerelac baby cereals: CEO
- 7 Nutritious and flavourful tiffin ideas to pack for school
- India's e-commerce market set to skyrocket as the country's digital economy surges to USD 1 Trillion by 2030
- Top 5 places to visit near Rishikesh
- Indian economy remains in bright spot: Ministry of Finance
- A surprise visit: Tesla CEO Elon Musk heads to China after deferring India visit